Mumbai-based speciality chemicals manufacturer of ethanolamines, alkanolamines, morpholine derivatives and gas-treating solvents, plus oilfield chemicals and industrial gas/engineering services
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 97 | 130 | 151 | 172 | 209 | 248 | 258 | 281 |
| Borrowings | 58 | 74 | 72 | 85 | 85 | 77 | 30 | 27 |
| Other Liabilities | 65 | 91 | 76 | 77 | 84 | 81 | 91 | 103 |
| Total Liabilities | 232 | 305 | 310 | 344 | 389 | 416 | 390 | 422 |
| AssetsFixed Assets | 75 | 73 | 84 | 80 | 80 | 80 | 79 | 76 |
| CWIP | 3 | 11 | 3 | 5 | 3 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 |
| Other Assets | 154 | 221 | 223 | 258 | 305 | 335 | 311 | 344 |
| Total Assets | 232 | 305 | 310 | 344 | 389 | 416 | 390 | 422 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 10 | 31 | 44 | -27 | 5 | 47 | 29 | 66 |
| Cash from Investing | -16 | -17 | -6 | -4 | -2 | -1 | -3 | -1 |
| Cash from Financing | 12 | -22 | 6 | -13 | 0 | -16 | -20 | -58 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -8 | 4 | 33 | -35 | 2 | 43 | 26 | 66 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (31.3×) and current (30.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 15.7% growth and a 30× exit, ₹201 only delivers your return if you pay ₹182. The price is currently baking in 18% growth.
EPS grows 15.7%/yr for 5 years, then fades to 6% over 2, exits at 30×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 15.7% | 7.68 |
| FY28 | 15.7% | 8.89 |
| FY29 | 15.7% | 10.28 |
| FY30 | 15.7% | 11.90 |
| FY31 | 15.7% | 13.77 |
| FY32 | 10.8% ·fade | 15.26 |
| FY33 | 6.0% ·fade | 16.18 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.